Where Will Evoke Pharma Inc (EVOK) Stock Go Next After It Has Risen 13.04% in a Week?

The market has been high on Evoke Pharma Inc (EVOK) stock recently. EVOK gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Evoke Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on EVOK!

See Full EVOK Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With EVOK Stock Today?

Evoke Pharma Inc (EVOK) stock is trading at $1.30 as of 10:24 AM on Tuesday, Nov 14, a rise of $0.02, or 1.56% from the previous closing price of $1.28. Volume today is more active than usual. So far 21,843 shares have traded compared to average volume of 6,715 shares. The stock has traded between $1.20 and $1.49 so far today. To see InvestorsObserver's Sentiment Score for Evoke Pharma Inc click here.

More About Evoke Pharma Inc

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa. Click Here to get the full Stock Report for Evoke Pharma Inc stock.